Literature DB >> 3970590

Measurement of rheumatoid factors by an enzyme-linked immunosorbent assay (ELISA) and comparison with other methods.

J L Bampton, T E Cawston, M V Kyle, B L Hazleman.   

Abstract

IgM rheumatoid factor (RF) was measured in the sera of 48 rheumatoid patients and of 48 age and sex-matched normal controls by the Rose-Waaler and latex agglutination tests, a rate nephelometer, and an enzyme-linked immunosorbent assay (ELISA). Good correlation was obtained between all assays. The rate nephelometer assay was the easiest and quickest to perform and gave results in international units/ml. The Rose-Waaler was the least sensitive assay and the most difficult to perform and interpret. Both the latex agglutination and the ELISA were sensitive, though some overlap of patient and control sera was seen with all the assays. In addition to IgM RF the ELISA was used to measure IgG RF and IgA RF in both rheumatoid and control sera. Although some normal sera had detectable amounts of IgG and IgA RF, the levels of both were significantly raised in the rheumatoid sera. IgG RF levels were lower after pepsin digestion of the sera, suggesting that IgM RF interfered with the assay for IgG RF unless this treatment was included.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3970590      PMCID: PMC1001560          DOI: 10.1136/ard.44.1.13

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis.

Authors:  C M PLOTZ; J M SINGER
Journal:  Am J Med       Date:  1956-12       Impact factor: 4.965

2.  Characterization and measurement of anti-IgG antibodies in human sera by radioimmunoassay (RIA).

Authors:  J Yamagata; E V Barnett; D W Knutson; H Nasu; D Chia
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

3.  IgM rheumatoid factor and low molecular weight IgM. An association with vasculitis.

Authors:  A N Theofilopoulos; G Burtonboy; J J LoSpalluto; M Ziff
Journal:  Arthritis Rheum       Date:  1974 May-Jun

4.  Raised IgG antiglobulin factors in Still's disease.

Authors:  G Torrigiani; B M Ansell; E E Chown; I M Roitt
Journal:  Ann Rheum Dis       Date:  1969-07       Impact factor: 19.103

5.  Solid-phase enzyme immunoassay of IgM-class rheumatoid factor: comparison of three methods for preparation of the solid-phase target IgG.

Authors:  B Ziola; H Tuokko
Journal:  Acta Pathol Microbiol Scand C       Date:  1980-06

6.  IgG-, IgM- and IgA-rheumatoid factors in healthy adults and rheumatoid patients determined by an indirect immunofluorescence method.

Authors:  H E Kallerup; E M Egeskjold; H Graudal
Journal:  Scand J Rheumatol       Date:  1979       Impact factor: 3.641

7.  IgG antiglobulins in rheumatoid arthritis and other arthritides: relationship with clinical features and other parameters.

Authors:  C Allen; C J Elson; D G Scott; P A Bacon; R C Bucknall
Journal:  Ann Rheum Dis       Date:  1981-04       Impact factor: 19.103

8.  IgA rheumatoid factor in the sera and saliva of patients with rheumatoid arthritis and Sjögren's syndrome.

Authors:  J V Dunne; D A Carson; H L Spiegelberg; M A Alspaugh; J H Vaughan
Journal:  Ann Rheum Dis       Date:  1979-04       Impact factor: 19.103

9.  IgG rheumatoid factor. Relationship to seropositive rheumatoid arthritis and absence in seronegative disorders.

Authors:  R M Pope; S J McDuffy
Journal:  Arthritis Rheum       Date:  1979-09

Review 10.  Rheumatoid factor: its nature, specificity, and production in rheumatoid arthritis.

Authors:  P M Johnson; W P Faulk
Journal:  Clin Immunol Immunopathol       Date:  1976-11
View more
  19 in total

1.  Can we develop simple response criteria for slow acting antirheumatic drugs?

Authors:  D L Scott; J E Dacre; A Greenwood; L Treasure; E C Huskisson
Journal:  Ann Rheum Dis       Date:  1990-03       Impact factor: 19.103

2.  Rate nephelometric determination of rheumatoid factor: comparison between Kallestad QM-300 and Beckman ICS-II (RF) methods.

Authors:  R J Collins; J C Neil; R J Wilson
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

3.  Determination of IgA- and IgM-rheumatoid factors in patients with rheumatoid arthritis with and without nephropathy.

Authors:  M Nakano; M Ueno; S Nishi; S Suzuki; H Hasegawa; T Watanabe; T Kuroda; S Ito; M Arakawa
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

4.  Clinical value of ELISA assays for IgM and IgG rheumatoid factors.

Authors:  R Stone; J S Coppock; P T Dawes; P A Bacon; D L Scott
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

5.  An investigation on rheumatoid factor of different immunoglobulin classes in hepatitis B virus carriers.

Authors:  K Watanabe; Y Ohkubo; Y Funahashi; T Nishimaki; T Moritoh; R Kasukawa; S Kaise; T Tomita; A Matsukawa
Journal:  Clin Rheumatol       Date:  1991-03       Impact factor: 2.980

6.  Enzyme-linked immunosorbent assay (ELISA) screening test for detection of rheumatoid factor.

Authors:  T Jonsson; J A Arnason; H Valdimarsson
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

7.  Enzyme immunoassay of complement-binding rheumatoid factors.

Authors:  A M Teppo; C P Maury
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

8.  IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA in rheumatoid arthritis.

Authors:  M Gioud-Paquet; M Auvinet; T Raffin; P Girard; M Bouvier; E Lejeune; J C Monier
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

9.  One year treatment with low dose methotrexate in rheumatoid arthritis: effect on class specific rheumatoid factors.

Authors:  A Spadaro; V Riccieri; A Sili Scavalli; E Taccari; A Zoppini
Journal:  Clin Rheumatol       Date:  1993-09       Impact factor: 2.980

10.  Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis.

Authors:  J Vencovský; S Machácek; L Sedová; J Kafková; J Gatterová; V Pesáková; S Růzicková
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.